PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
[21]   A PHASE-II TRIAL OF VINCRISTINE IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
BROUN, GO ;
BLESSING, JA ;
EDDY, GL ;
ADELSON, MD .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01) :18-21
[22]   CIS-PLATINUM IN TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP [J].
THIGPEN, T ;
SHINGLETON, H ;
HOMESLEY, H ;
LAGASSE, L ;
BLESSING, J .
CANCER, 1981, 48 (04) :899-903
[23]   PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SLAYTON, RE ;
BLESSING, JA ;
BEECHAM, J ;
DISAIA, PJ .
CANCER TREATMENT REPORTS, 1987, 71 (09) :869-870
[24]   Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group [J].
Muggia, FM ;
Blessing, JA ;
McGehee, R ;
Monk, BJ .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :483-487
[25]   PHASE-II TRIAL OF AMSA IN PATIENTS WITH ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
BONOMI, P ;
BLESSING, JA ;
SEDLACEK, TV ;
HOMESLEY, HD ;
DISAIA, PJ .
CANCER TREATMENT REPORTS, 1983, 67 (02) :197-198
[26]   Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study [J].
Rose, PG ;
Blessing, JA ;
Arseneau, J .
GYNECOLOGIC ONCOLOGY, 1996, 62 (01) :100-102
[27]   PHASE-II TRIAL OF VP-16-213 IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE OVARY - GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SLAYTON, RE ;
CREASMAN, WT ;
PETTY, W ;
BUNDY, B ;
BLESSING, JA .
CANCER TREATMENT REPORTS, 1979, 63 (11-1) :2089-2092
[28]   PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
EHRLICH, CE ;
CREASMAN, WT ;
CURRY, S ;
BLESSING, JA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03) :273-275
[29]   PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN NONSQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SUTTON, GP ;
BLESSING, JA ;
DISAIA, PJ ;
MCGUIRE, WP .
GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :48-50
[30]   PHASE-II TRIAL OF CISPLATIN IN THE TREATMENT OF PATIENTS WITH ADVANCED OR RECURRENT MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
THIGPEN, JT ;
BLESSING, JA ;
ORR, JW ;
DISAIA, PJ .
CANCER TREATMENT REPORTS, 1986, 70 (02) :271-274
12345